XML 120 R26.htm IDEA: XBRL DOCUMENT

Quarterly financial data (unaudited)

12 Months Ended

Oct. 31, 2011

Quarterly financial data (unaudited) [Abstract]

Quarterly financial data (unaudited)

Note 19 — Quarterly financial data (unaudited)


		First				Second				Third				Fourth
2011:
Sales		$	270,962			$	318,924			$	312,255			$	331,018
Gross margin			166,171				197,752				188,050				196,459
Net income			45,897				65,242				56,550				54,675
Earnings per share:
Basic			0.67				0.96				0.83				0.82
Diluted			0.67				0.95				0.82				0.81
2010:
Sales		$	220,589			$	251,659			$	279,121			$	290,182
Gross margin			131,675				153,867				165,801				170,271
Net income			26,732				32,431				55,329				53,556
Earnings per share:
Basic			0.40				0.48				0.81				0.79
Diluted			0.39				0.47				0.80				0.78

The sum of the per-share amounts for the four quarters of 2011 and 2010 do not equal the annual per-share amounts due to differences in the average number of shares outstanding during the respective periods.

During the first quarter of 2011, net income tax benefits of $1,242 were recorded as a result of the Tax Relief, Unemployment Insurance Reauthorization, and Job Creation Act of 2010 that was passed by the U.S. Congress and signed by the President in December 2010. During the third quarter of 2011, a favorable adjustment to unrecognized tax benefits primarily related to settlements with tax authorities reduced income taxes by $2,027. The third quarter also included expense of $3,136 related to a fee paid to withdraw from a multiemployer employee pension fund in Japan.

During the first quarter of 2010, net income tax benefits of $3,500 were recorded as a result of the consolidation of certain operations and legal entities. During the second quarter of 2010, an additional tax charge of $5,255 was recorded resulting from the enactment of the Patient Protection and Affordable Care Act and the subsequent enactment of the Health Care and Education Reconciliation Act of 2010. The charge was due to a reduction in the value of our deferred tax asset as a result of a change to the tax treatment associated with Medicare Part D subsidies. During the third quarter of 2010, a tax benefit of $10,700 was recognized as a result of the write-off of the tax basis of the UV graphic arts business sold on June 30, 2010.

This element can be used to disclose the entire quarterly financial data disclosure in the annual financial statements as a single block of text. The disclosure includes a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished. Alternatively, the details of this disclosure can be reported using the elements in this group, or by using other taxonomy elements and applying the appropriate quarterly date and period contexts when creating an instance document. For example, the element for "Interest and Dividend Income, Operating" may be used by financial institutions from the Statement of Income, applying the appropriate quarterly date and period context when creating an instance document.

+ References+ Details